Cargando…

Household clustering of SARS-CoV-2 variant of concern B.1.1.7 (VOC-202012–01) in England

Detalles Bibliográficos
Autores principales:	Chudasama, Dimple Y., Flannagan, Joe, Collin, Simon M., Charlett, André, Twohig, Katherine A., Lamagni, Theresa, Dabrera, Gavin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Ltd on behalf of The British Infection Association. 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8085110/ https://www.ncbi.nlm.nih.gov/pubmed/33933529 http://dx.doi.org/10.1016/j.jinf.2021.04.029

Ejemplares similares

Impact of SARS-CoV-2 Alpha variant (B.1.1.7) on prisons, England
por: Vusirikala, Amoolya, et al.
Publicado: (2022)

Effect of Returning University Students on COVID-19 Infections in England, 2020
por: Leeman, David, et al.
Publicado: (2022)

Household transmission of COVID-19 cases associated with SARS-CoV-2 delta variant (B.1.617.2): national case-control study
por: Allen, Hester, et al.
Publicado: (2021)

Investigation of an outbreak of symptomatic SARS-CoV-2 VOC 202012/01-lineage B.1.1.7 infection in healthcare workers, Italy
por: Loconsole, Daniela, et al.
Publicado: (2021)

Making the invisible visible: using national surveillance data to identify people experiencing homelessness in England with COVID-19
por: Capelastegui, Fernando, et al.
Publicado: (2023)

Surge in SARS-CoV-2 transmission in school-aged children and household contacts, England, August to October 2021
por: Chudasama, Dimple Y, et al.
Publicado: (2021)

Differential impact of quarantine policies for recovered COVID-19 cases in England: a case cohort study of surveillance data, June to December 2020
por: Merrick, Rachel, et al.
Publicado: (2022)

Risk of hospital admission for patients with SARS-CoV-2 variant B.1.1.7: cohort analysis
por: Nyberg, Tommy, et al.
Publicado: (2021)

Near-Complete Genome Sequence of a SARS-CoV-2 VOC 202012/01 Strain in Peru
por: Padilla-Rojas, C., et al.
Publicado: (2021)

VOC 202012/01 Variant Is Effectively Neutralized by Antibodies Produced by Patients Infected before Its Diffusion in Italy
por: Rondinone, Valeria, et al.
Publicado: (2021)

Discovery of Taroxaz-104: The first potent antidote of SARS-CoV-2 VOC-202012/01 strain
por: Rabie, Amgad M.
Publicado: (2021)

Dying of VOC-202012/01 — multimodal investigations in a death case of the SARS-CoV-2 variant
por: Heinrich, Fabian, et al.
Publicado: (2021)

Rapid screening for SARS-CoV-2 VOC-Alpha (202012/01, B.1.1.7) using the Allplex™ SARS-CoV-2/FluA/FluB/RSV Assay
por: Giovacchini, Nicla, et al.
Publicado: (2021)

Assessment of mortality and hospital admissions associated with confirmed infection with SARS-CoV-2 Alpha variant: a matched cohort and time-to-event analysis, England, October to December 2020
por: Dabrera, Gavin, et al.
Publicado: (2022)

Evaluation of the Diagnostic Value of Hematologic Parameters and Ratios in SARS-CoV-2 VOC-202012/01 Mutant Population
por: Seyit, Murat, et al.
Publicado: (2022)

Estimating COVID-19 cases infected with the variant alpha (VOC 202012/01): an analysis of screening data in Tokyo, January-March 2021
por: Murayama, Hiroaki, et al.
Publicado: (2021)

Comparative transmission of SARS-CoV-2 Omicron (B.1.1.529) and Delta (B.1.617.2) variants and the impact of vaccination: national cohort study, England
por: Allen, Hester, et al.
Publicado: (2023)

The impact of COVID‐19 on residents of long‐term care facilities with learning disabilities and/or autism
por: Tessier, Elise, et al.
Publicado: (2023)

Performance of the Abbott SARS-CoV-2 IgG II Quantitative Antibody Assay Including the New Variants of Concern, VOC 202012/V1 (United Kingdom) and VOC 202012/V2 (South Africa), and First Steps towards Global Harmonization of COVID-19 Antibody Methods
por: English, Emma, et al.
Publicado: (2021)

SARS-CoV-2 Variant of Concern 202012/01 Has about Twofold Replicative Advantage and Acquires Concerning Mutations
por: Grabowski, Frederic, et al.
Publicado: (2021)

Early assessment of diffusion and possible expansion of SARS-CoV-2 Lineage 20I/501Y.V1 (B.1.1.7, variant of concern 202012/01) in France, January to March 2021
por: Gaymard, Alexandre, et al.
Publicado: (2021)

Epidemiology of COVID-19 in Prisons, England, 2020
por: Rice, Wendy M., et al.
Publicado: (2021)

Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial
por: Emary, Katherine R W, et al.
Publicado: (2021)

Rapid Spread of the SARS-CoV-2 Variant of Concern 202012/01 in Southern Italy (December 2020–March 2021)
por: Loconsole, Daniela, et al.
Publicado: (2021)

Controlling healthcare-associated transmission of SARS-CoV-2 variant of concern 202012/01 in a large hospital network
por: Duverger, C., et al.
Publicado: (2021)

Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study
por: Twohig, Katherine A, et al.
Publicado: (2022)

Implications of the Emergence of a New Variant of SARS-CoV-2, VUI-202012/01
por: Rahimi, Farid, et al.
Publicado: (2021)

Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study
por: Challen, Robert, et al.
Publicado: (2021)

New COVID-19 Variant, VUI-202012/01: Molecular Change, Epitope Alteration, and Implication for Vaccine Efficacy
por: Joob, Beuy, et al.
Publicado: (2021)

Invasive Group B Streptococcus Infections in Adults, England, 2015–2016
por: Collin, Simon M., et al.
Publicado: (2020)

Genome Sequence of a SARS-CoV-2 VUI 202012/01 Strain Identified from a Patient Returning from London, England, to the Apulia Region of Italy
por: Loconsole, Daniela, et al.
Publicado: (2021)

Timeliness and completeness of laboratory-based surveillance of COVID-19 cases in England
por: Clare, T., et al.
Publicado: (2021)

The SARS-CoV-2 B.1.351 lineage (VOC β) is outgrowing the B.1.1.7 lineage (VOC α) in some French regions in April 2021
por: Roquebert, Bénédicte, et al.
Publicado: (2021)

Rapid rise in COVID-19 among young people in England – learning for the future
por: Twohig, K.A., et al.
Publicado: (2023)

Comparing susceptibility and contagiousness in concurrent outbreaks with a non-VOC and the VOC SARS-CoV-2 variant B.1.1.7 in daycare centers in Hamburg, Germany
por: Nakel, Jacqueline, et al.
Publicado: (2022)

Two-step strategy for the identification of SARS-CoV-2 variant of concern 202012/01 and other variants with spike deletion H69–V70, France, August to December 2020
por: Bal, Antonin, et al.
Publicado: (2021)

Case fatality risk of the SARS-CoV-2 variant of concern B.1.1.7 in England, 16 November to 5 February
por: Grint, Daniel J, et al.
Publicado: (2021)

Genomic monitoring of the SARS-CoV-2 B1.1.7 (WHO VOC Alpha) in the Sao Paulo state, Brazil
por: Slavov, Svetoslav Nanev, et al.
Publicado: (2022)

Evolutionary history and introduction of SARS-CoV-2 Alpha VOC/B.1.1.7 in Pakistan through international travelers
por: Nasir, Asghar, et al.
Publicado: (2022)

Dieckol and Its Derivatives as Potential Inhibitors of SARS-CoV-2 Spike Protein (UK Strain: VUI 202012/01): A Computational Study
por: Aatif, Mohammad, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8hoj6ggcej2bf4jngsrm1nnsv9